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Abstract: We report a case of orbital metastasis in a previously diagnosed metastatic breast cancer in a 46-year old woman presenting 
with diplopia and proptosis of her left eye bulb. An orbital computed-tomography (CT) and a magnetic resonance imaging (MRI) both 
revealed an intra-orbital extra-bulbar mass of 1.5 × 3 cm in size, in the left orbit. The patient had been diagnosed with stage IV breast 
cancer 4 years before. She had received chemotherapy with docetaxel and was on hormone therapy at the time of presentation of her eye 
symptoms. Current treatment included systemic combination therapy with docetaxel and capecitabine as well as local irradiation with 
stereotactic radiosurgery (cyberknife). There was a gradual improvement of local symptoms and signs. The metastatic involvement of 
the orbit in malignant tumors is a rarely diagnosed condition. Breast cancer accounts for the majority of these cases. The appearance of 
eye symptoms in patients with a history of cancer should always be investigated with a consideration of ocular metastatic disease.
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Introduction
Breast cancer can metastasize to many sites, but the 
orbit is an infrequent location and a comparatively rare 
site of distribution among the ocular area structures. 
Longer survival of patients with metastatic disease as 
well as advances in diagnostic imaging may explain 
the increasing frequency of ocular involvement1 that 
occurs in up to one third of breast cancer patients.2 
Bone metastases as a sole metastatic site in breast can-
cer portend a good prognosis as opposed to visceral 
disease  and  are  seen  frequently  in  the  ER/PR  (+) 
Her2/Neu (-) subset of the disease. Nevertheless, they 
may present a particular clinical problem if they are 
neighboring sensitive structures such as the spine or 
the eye, as in this case, and may need urgent treatment 
to preserve patient’s quality of life and function.
case Report
A 46-year old woman, with a history of a grade 2, hor-
mone receptor-positive, HER2-negative ductal adeno-
carcinoma of the left breast, presented with diplopia, 
exophthalmos, decreased visual acuity and pain in 
her left eye.
Initial diagnosis was made 4 years previously, when 
the patient suffered a pathologic right femor fracture. 
Clinical examination revealed skin retraction and an 
estimated 4 × 5 cm palpable mass in the left breast. 
The area of the right femor was treated with one dose 
of  analgesic  external-beam  radiotherapy.  Patient 
subsequently underwent a lumpectomy. A total hip 
arthroplasty was performed a few days later. Breast 
carcinoma metastatic to the right femoral bone was 
confirmed histopathologically. Staging CTs of thorax 
and abdomen and a bone scan were negative for other 
metastatic lesions.
Preoperatively elevated serum CA 19-9 and CA 
15-3 levels immediately normalized after surgery and 
the patient was started on docetaxel at 30 mg/m2 weekly 
for 12 weeks followed by hormonal therapy, consisting 
of goserelin and tamoxifen, as well as zolendronic 
acid. Further metastatic bone lesions developed in the 
spine and the patient received analgesic radiotherapy 
(30Gy) to the lumbar spine. Due to progression of bone 
disease hormonal therapy was switched to anastrazole 
and then to letrozole.
Four years after the initial diagnosis, the patient 
presented with diplopia to all gaze directions, exophthal-
mos and bulb proptosis. Ophthalmologic examination 
revealed reduced visual acuity to 4/10 in left eye. A CT 
and MRI of the orbits and head were performed, both 
showing a solid, intra-orbital, extra-bulbar, 1.5 × 3 cm 
mass, occupying the inferior quadrant of the left orbit 
(Figs.  1–3).  Concomitant  serum  tumor  markers 
elevation  together  with  the  imaging  findings,  were 
most compatible with metastatic disease in the orbit. 
A combined chemotherapy treatment with docetaxel 
75 mg/m2 intravenously on day 1 and capecitabine 
1000 mg/m2 per os twice daily for 14 out of every 
21 days was started. Additionally, the orbital mass was 
irradiated with the use of a cyberknife image-guided 
stereotactic radiosurgery system in one session, with 
a total dose of 1700 cGy being delivered to the tumor 
with 6MV photons. Eye symptoms resolved almost 
completely during the following weeks, while there 
was also a gradual decrease in serum tumor marker 
levels.  An  orbital  CT  was  performed  7  months 
after diagnosis of orbital involvement and disclosed 
regression of the tumor, measuring 0.6 cm by 1.7 cm 
(Fig. 4). The patient remains free from ocular symp-
toms 18 months after stereotactic treatment.
Discussion
We describe a case of orbital metastasis presenting as 
a relapse of a known, previously treated, metastatic 
breast carcinoma.
Orbital metastases represent a small but increasing 
percentage of all orbital tumors, reported in different 
case studies and series to have an incidence of 1% to 
13%. Breast cancer is by far the most common primary 
site, accounting for 28.5%–58.8% of cases of orbital 
metastases, followed by lung, prostate, gastrointestinal, 
Figure 1. orbital CT of the patient before treatment for orbital metastasis 
showing a soft-tissue mass inferior the left bulb.orbital metastasis of breast cancer
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kidney  and  skin  (melanoma)  cancers.1–5  Unilateral 
disease is the usual presentation while intra-orbital 
anatomical distribution involves  predominantly the 
lateral  and  superior  quadrants.1  Orbital  metastatic 
lesions usually present in patients with established 
diagnosis of disseminated cancer and there is a long 
medial time interval of 4.5–6.5 years from diagnosis 
for breast carcinoma. The longest intervals from the 
diagnosis of primary breast cancer to the presentation 
of orbital metastasis are 25 and 28 years respectively.6,7 
However, in up to 25% of cases, orbital metastasis is 
the initial finding of a previously undetected primary 
cancer.1,8–12
Due to a tissue-specific preference of breast cancer 
to extra-ocular muscle and surrounding orbital fat, 
diplopia resulting from mobility deficits is a prevalent 
symptom. Other common symptoms and signs include 
proptosis, eyelid swelling or visible mass, pain, palpe-
bral ptosis, bulb divergence and blurred vision, caused 
by infiltration or compression. Enophthalmos is a less 
common but distinctive sign of orbital infiltration by 
scirrhous breast adenocarcinoma.1,5,13,14 In a recently 
reported case, orbital metastasis presented as neuro-
trophic keratitis.15
Definite diagnosis of an orbital lesion requires an 
orbital biopsy (either FNA or open biopsy). However, 
in patients with known metastatic cancer, as in our 
case, the latter may be avoided if there is a strong 
clinical and imaging suspicion for metastatic disease. 
It should only be done in patients with no known previ-
ous history of cancer and in patients in whom the orbit 
is the only site of suspected metastasis in whom hav-
ing a definite diagnosis would change the overall man-
agement of the patient.1 Metastatic lesions to the orbit 
usually present as irregularly shaped masses on non-
contrast CT which are isodense to muscle. With con-
trast injection, they show slight enhancement. Orbital 
bony  wall  involvement  is  also  a  common  finding, 
especially  in  prostate  cancer.  On  MRI,  metastatic 
disease is usually hypointense to fat on T1-weighted 
images  (T1WI)  and  hyperintense  to  fat  on  T2WI. 
Figure 2. orbital MRI of the patient before treatment for orbital metastasis 
showing a T1-weighed orbital tumor, hypointense compared to fat.
Figure 3. orbital MRI of the patient before treatment for orbital metastasis 
showing a T2-weighed orbital tumor, hyperintense compared to fat.
Figure 4. orbital CT of the patient 7 months after initiation of treatment 
for orbital metastasis: tumor now measuring 1.7 × 0.6 cm.Vlachostergios et al
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This  appearance  may  help  to  differentiate  it  from 
an orbital pseudotumor, which is usually isointense 
to fat on T2WI. When hyperintense lesions are seen 
on T1WI, a very vascular metastasis (e.g. thyroid, 
renal) or melanoma metastasis should be suspected.16 
The combined involvement of the orbit and adjacent 
structures, such as the paranasal sinuses, is a rare con-
dition revealed by imaging studies.17
In  addition  to  metastasis,  differential  diagnosis 
of  an  orbital  process  should  include  inflammatory 
lesions, benign tumors (such as hemangiomas) and 
lymphoproliferative  disorders.  Idiopathic  orbital 
inflammatory syndrome (IOIS or orbital pseudotumor), 
sarcoidosis and Wegener granulomatosis are inflam-
matory conditions that may present in similar man-
ners. Given that inflammatory signs are common in 
orbital metastases from breast cancer, they could be 
misdiagnosed as thyroid orbitopathy, cellulitis, myo-
sitis, scleritis or endophthalmitis. The distinguishing 
feature of orbital metastases is a rapid onset and pro-
gressive  course  with  combined  motor  and  sensory 
deficits, non-responding to antibiotics or steroids.18,19
Treatment  for  orbital  metastases  is  inevitably 
palliative, given that hematogenous spread of cancer to 
the orbit is a sign of systemic disease and involvement 
of other sites. Surgical intervention is generally not 
recommended, unless it is performed for diagnostic 
purpose (biopsy) in patients with no previous history 
of  cancer20–28  or  as  palliation  (tumor  resection 
or  enucleation)  in  cases  of  unmanageable  local 
symptoms.1
The main treatment option is radiotherapy, with 
high  rates  (60%–80%)  of  clinical  improvement  of 
local symptoms and vision. External-beam irradia-
tion is the most common and accessible modality, 
with a total dose of 20–40 Gy delivered in fractions 
over 1–2 weeks.1,5
Stereotactic radiation therapy (SRT) has recently 
evolved  as  an  alternative  modality,  in  an  effort  to 
apply  high  doses  of  radiation  to  a  well-defined 
volume with steep dose gradients outside the target 
volume.20  A  complex  mixture  of  image-guided 
radiation using CT, MRI and stereotactic localization 
defines  stereotactic  radiosurgery  (SRS).  Although 
not available in all treatment settings, SRT and SRS 
require  a  shorter  treatment  course  compared  with 
external-beam irradiation, thus contributing to a better 
quality of life.20 To our knowledge, only two other 
cases of orbital metastases from breast cancer treated 
with the stereotactic method have been reported.21
Due to the fact that most patients have concomitant 
progressive systemic disease, chemotherapy followed 
by hormone therapy in cases of hormone-sensitive 
tumors is indicated in patients with good performance 
status. A contribution to the palliative result obtained 
by  radiotherapy  can  be  expected  with  systemic 
treatment.22  In  contrast,  responses  with  systemic 
chemotherapy alone have been reported in choroidal 
metastases. In one recent case of choroidal metastasis 
of breast cancer a dramatic response was observed 
with transtuzumab and vinorelbine.23
The  combination  of  radiotherapy,  delivered  in 
eight fractions of 4Gy, and hyperthermia was recently 
proposed as a treatment for patients with recurrent 
breast cancer in the orbital region. Local hyperthermia 
treatment feasibility in the orbit is restricted by the 
depth of the tumor from the skin and the need to 
avoid microwave-induced high temperatures reached 
in the lens.24
Prognosis of patients with metastatic orbital tumors 
is rather poor, with a median survival ranging from 
22 to 31 months for breast cancer.1,5 Nevertheless, 
rare cases of long-term survival after the diagnosis of 
breast cancer presenting as an orbital mass have been 
reported.10,11,18
Table 1 summarises recent cases of orbital metas-
tases from breast cancer reported in English literature. 
Oncologists and ophthalmologists should be vigilant 
for the observation and interpretation of symptoms 
and signs compatible with ocular disease in patients 
with an established diagnosis of breast cancer. A com-
bination of local and systemic treatments may help 
preserve vision and patients’ quality of life.
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